Prognostic values of tumor endothelial markers in patients with colorectal cancer

World Journal of Gastroenterology

Volumn 11, Issue 9, 2005, Pages 1283-1286

  Rmali, K A ^a   Puntis, M C A ^a   Jiang, W G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Angiogenesis; Colon cancer; Dukes stages; Tumor endothelial markers

Indexed keywords

COMPLEMENTARY DNA; ENDOSIALIN; ONCOPROTEIN; TUMOR ENDOTHELIAL MARKER 2; TUMOR ENDOTHELIAL MARKER 6; TUMOR ENDOTHELIAL MARKER 7; TUMOR ENDOTHELIAL MARKER 7R; TUMOR ENDOTHELIAL MARKER 8; TUMOR ENDOTHELIAL MARKERS; TUMOR MARKER; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; COLORECTAL CANCER; DISEASE COURSE; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; PROGNOSIS; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STAINING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

EID: 15844403827     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i9.1283     Document Type: Article

References (18)

1. Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958; 12: 309-320
2. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, Colquhoun K. A multivariate analysis of clinical and pathological variables in prognosis after rescetion of large bowel cancer. Br J Cancer 1985; 72: 1424-1429
3. Fielding LP, Phillips RK, Fry JS, Hittinger R. Prediction of outcome after curative resection for large bowel cancer. Lancet 1986; 2: 904-907
4. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2: 727-739
5. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182-1186
6. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lai A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. Genes expression in human tumor endothelium. Science 2000; 289: 1197-1201
7. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001; 61: 6649-6655
8. Nanda A, St Croix B. Tumor endothelial markers: New targets for cancer therapy. Curr Opin Oncol 2004; 16: 44-49
9. Rmali KA, Al-Rawi MA, Parr C, Puntis MC, Jiang WG. Up-regulation of tumor endothelial marker-8 by interleukin-1 β and its impact in IL-1 β induced angiogenesis. Int J Mol Med 2004; 14 75-80
10. Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K, Mansel RE. Prognostic value of Rho familty and and rho-GDIs in breast cancer. Clin Cancer Res 2003; 9: 6432-6440
11. Jiang WG, Douglas-Jones A, Mansel RE. Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int J Cancer 2003; 106: 752-757
12. Davies G, Cunnick GH, Mansel RE, Malcolm DM, Jiang WG. Level of expression of endothelial markers specific to tumour -associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 2004; 21: 31-37
13. Colombatti AP, Bonaldo P. The super family of proteins with von willebrand factor type A-like domains: One theme common to components of extracellular matrix, haemostasis, cellular adhesion, and defense mechanisms. Blood 1991; 77: 2305-2315
14. Lee J, Rieu P, Arnaout MA, Liddington R. Crystal structure of the A domain from the subunit of integrin CR3 (CD11b/CD18). Cell 1995; 80: 631-638
15. Dickeson SK, Santoro S. Ligand recognition by the I domain-containing integrins. Cell Mol Life Sci 1998; 54: 556-566
16. Van der Vieren M, Crowe DT, Hoekstra D, Vazeux R, Hoffman PA, Grayson MH, Bochner BS, Gallatin WM, Staunton DE. The leukocyte integrin Dβ2 binds VCAM-1: Evidence for a binding interface between I domain and VCAM-1. J Immunol 1999; 163: 1984-1990
17. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91-100
18. McCarthy M. Antiangiogenesis drug promising for metastasis colorectal cancer. Lancet 2003; 361: 1959